Living with Parkinson’s – The Impact of Treatment Choices
An exclusive panel discussion, featuring the following industry leading experts: Werner Poewe, MD, PhD; Angelo Antonini MD, PhD & Pablo Mir, MD, PhD
CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 1 (one) CME credit to this online programme. To obtain your CME credits, complete the evaluation form at www.eacic.eu.
This e-Roundtable discussion was supported and funded by Britannia Pharmaceuticals Limited
HOW TO OBTAIN CME CREDITS
Participants requesting CME credits are required to complete the online evaluation form on the EACIC website www.eacic.eu.
Please follow the below steps to receive your CME Certificate.
Go to the EACIC website www.eacic.eu
- Click on “CLAIM YOUR CME CREDITS”
- Choose the option “I AM ALREADY REGISTERED” or “I AM NOT REGISTERED”
- The Event Code for this event is ORUEN2020
- Log on or register
- Complete the online evaluation form
- Press “save”
- Your CME certificate will be automatically emailed to the address provided
The deadline to complete the evaluation form is 30 April 2021
APO-go® Apomorphine hydrochloride is indicated for the treatment of motor fluctuations (“on-off” phenomena) in patients with Parkinson’s disease which are not sufficiently controlled by an oral anti-Parkinson medication. Click here for Prescribing information
Adverse events should be reported. Reporting forms and information. can be found at mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should be reported to Britannia Pharmaceuticals Ltd at email@example.com or 01483 920 763.
Job Code: APO2-1020-11628 Date of Preparation: October 2020